Satellite Symposium on "Novel Strategies for Intervention in Neurodegenerative Di

描述（由申请人提供）：申请资金用于2009年8月30日至9月2日在台湾台北举行的题为“神经退行性疾病的新型干预策略”的卫星研讨会的部分支持。本次研讨会由国际神经化学学会（ISN）/亚太神经化学学会（APSN）主办，将于2009年8月23日至29日在韩国釜山举行。这次研讨会的主要目标是汇集国际科学家，讨论一个对人类健康极为重要的主题，特别关注神经退行性疾病的干预策略，特别强调阿尔茨海默病，帕金森病和中风。科学会议将包括针对神经脂质的干预策略，中风，阿尔茨海默病和其他神经退行性疾病的治疗方法，以及通过营养保健品和植物药进行干预。本次研讨会包括全体讲座，演讲，海报和讨论会，以确定关键问题和未来研究的有前途的方向。研讨会将为年轻科学家和代表性不足的少数民族提供机会，与杰出的神经科学家互动和交流信息，并建立合作关系。来自美国、欧洲和亚洲的超过45位世界知名的神经退行性疾病研究人员表示有兴趣参加这次研讨会并展示他们最近的研究结果。本申请为30名美国高级研究人员和10名美国初级和代表性不足的少数民族研究人员寻求部分旅行支持，以便提供参加本次研讨会的机会。 公共卫生相关性：神经退行性疾病尤其是中风、阿尔茨海默病和帕金森病的患病率在未来十年将增加。中风是美国第三大死亡原因，也是老年人残疾的最常见原因。阿尔茨海默病是最常见的痴呆症，影响美国400万人。鉴于目前的药物没有持久的认知或运动改善的确凿证据，有效和安全的解决方案的公共卫生价值是显而易见的。

DESCRIPTION (provided by applicant): Funding is requested for partial support of a satellite symposium entitled "Novel Interventional Strategies in Neurodegenerative Diseases" to be held in Taipei, Taiwan, August 30-September 2, 2009. This symposium is sponsored by the International Society for Neurochemistry (ISN)/Asian Pacific Society of Neurochemistry (APSN) which will be having the biannual meeting in Busan, Korea, August 23-29, 2009. The major goal for this symposium is to bring together international scientists to address a topic of immense importance to human health with special focus on intervention strategies on neurodegenerative diseases, with particular emphasis on Alzheimer's disease, Parkinson's disease and stroke. Scientific sessions will include intervention strategies targeting neurolipids, therapeutics for stroke, Alzheimer's disease, and other neurodegenerative diseases, and intervention through nutraceuticals and botanicals. This symposium is comprised of plenary lectures, presentations, posters and a discussion session to identify key issues and promising direction of future research. The symposium will provide opportunities for young scientists and underrepresented minorities to interact and exchange information with prominent neuroscientists and establish collaborations. More than 45 world renowned investigators from US, Europe, and Asia working in the neurodegeneration area have expressed interest in participating in this symposium and presenting their recent findings. This application seeks partial travel support for 30 US senior investigators and 10 junior and underrepresented minority investigators in US in order to provide opportunity to participate in this symposium. PUBLIC HEALTH RELEVANCE: The prevalence of neurodegenerative diseases especially, stroke, Alzheimer's and Parkinson's diseases will increase in the next decade. Stroke is the third leading cause of death in the US and the most common cause of disabilities in aging adults. Alzheimer's disease is the most common dementia affecting 4 million people in the US. In view of the fact that no conclusive evidence exists for long-lasting cognitive or motor improvement with the current drugs, the Public Health value of efficacious and safe solutions is apparent.